These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15784562)

  • 41. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.
    Skinner MA; Keen DL; Parlane NA; Yates GF; Buddle BM
    Tuberculosis (Edinb); 2002; 82(1):15-22. PubMed ID: 11914058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.
    Maue AC; Waters WR; Palmer MV; Nonnecke BJ; Minion FC; Brown WC; Norimine J; Foote MR; Scherer CF; Estes DM
    Vaccine; 2007 Jun; 25(24):4735-46. PubMed ID: 17499400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
    Kalra M; Grover A; Mehta N; Singh J; Kaur J; Sable SB; Behera D; Sharma P; Verma I; Khuller GK
    Clin Immunol; 2007 Nov; 125(2):173-83. PubMed ID: 17766185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.
    Vordermeier HM; Whelan A; Cockle PJ; Farrant L; Palmer N; Hewinson RG
    Clin Diagn Lab Immunol; 2001 May; 8(3):571-8. PubMed ID: 11329460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization.
    Brown CA; Brown IN; Swinburne S
    Tubercle; 1985 Dec; 66(4):251-60. PubMed ID: 4082281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.
    Orme IM; Collins FM
    Infect Immun; 1984 Apr; 44(1):28-32. PubMed ID: 6423543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.
    Wedlock DN; Denis M; Skinner MA; Koach J; de Lisle GW; Vordermeier HM; Hewinson RG; van Drunen Littel-van den Hurk S; Babiuk LA; Hecker R; Buddle BM
    Infect Immun; 2005 Jun; 73(6):3540-6. PubMed ID: 15908383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Original Mycobacterial Sin, a consequence of highly homologous antigens?
    Jenkins AO; Michel A; Rutten V
    Vet Microbiol; 2017 May; 203():286-293. PubMed ID: 28619159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.
    Ferraz JC; Stavropoulos E; Yang M; Coade S; Espitia C; Lowrie DB; Colston MJ; Tascon RE
    Infect Immun; 2004 Dec; 72(12):6945-50. PubMed ID: 15557616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.
    Weir RE; Black GF; Nazareth B; Floyd S; Stenson S; Stanley C; Branson K; Sichali L; Chaguluka SD; Donovan L; Crampin AC; Fine PE; Dockrell HM
    Clin Exp Immunol; 2006 Dec; 146(3):390-9. PubMed ID: 17100757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines.
    Murray PJ; Aldovini A; Young RA
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):934-9. PubMed ID: 8570663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.
    Gröschel MI; Sayes F; Shin SJ; Frigui W; Pawlik A; Orgeur M; Canetti R; Honoré N; Simeone R; van der Werf TS; Bitter W; Cho SN; Majlessi L; Brosch R
    Cell Rep; 2017 Mar; 18(11):2752-2765. PubMed ID: 28297677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions.
    Etna MP; Giacomini E; Pardini M; Severa M; Bottai D; Cruciani M; Rizzo F; Calogero R; Brosch R; Coccia EM
    Sci Rep; 2015 Nov; 5():17078. PubMed ID: 26602835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of L-alanine dehydrogenase to in vivo persistence and protective efficacy of the BCG vaccine.
    Scandurra GM; Ryan AA; Pinto R; Britton WJ; Triccas JA
    Microbiol Immunol; 2006; 50(10):805-10. PubMed ID: 17053316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.